| 316) Risk perception varied geographically alon |
| 317) al, and social drivers of population heat risk perception and how they interact to i |
| 318) research demonstrates a link between heat risk perception and population response to |
| 319) lished up to March 2020 and investigating risk perception determinants for respirato |
| 320) A miscellaneous operationalization of risk perception emerged, including the lik |
| 321) Understanding the determinants of risk perception for COVID-19 might help to |
| 322) evidence on the possible determinants of risk perception for COVID-like diseases. |
| 323) Results revealed risk perception influences a person's expo |
| 324) mptoms, fatigue, daily activities, stroke risk factors, and cognitive exertion. |
| 325) ead to better health care outcomes, lower risk factors, and improved interventions r |
| 326) odemographic correlates, associations, or risk factors, and nine studies examined me |
| 327) Prognosis/ risk factors, epidemiology, and coagulatio |
| 328) Establishing risk factors, examining sex differences an |
| 329) e captured detailed data on demographics, risk factors, pre-COVID-19 Rockwood frailt |
| 330) addressed prevalence, severity, etiology, risk factors, preventive methods, screenin |
| 331) ized approaches for smoking cessation and risk prediction for tobacco-related diseas |
| 332) survival when incorporated into existing risk prediction models. |
| 333) ncorporating endostatin into existing PAH risk prediction models. |
| 334) Adding endostatin to existing PAH risk prediction strategies improves PAH ri |
| 335) mpared to null models based on the REVEAL risk prediction tool and European Society |
| 336) calibration examining the reliability in risk prediction was performed using either |
| 337) rvations and the implications for genetic risk prediction. |
| 338) ersely associated with a pediatric asthma risk stratification based on multiple peri |
| 339) nfirm causality, use of this finding as a risk stratification biomarker is promising |
| 340) tatus could be utilized as a predictor of risk stratification for recurrence and to |
| 341) tokine biomarker signatures might improve risk stratification in LTBI. |
| 342) Accurate detection and risk stratification of latent tuberculosis |
| 343) by these characteristics could facilitate risk stratification or new therapeutic tar |
| 344) dementia screening battery to identify at-risk individuals with DS in primary care s |
| 345) s of the disease, as well as detecting at-risk individuals. |
| 346) ' S309-CAR-NK cells for treatment in high-risk individuals as well as provide an alt |
| 347) media were significantly enriched in high-risk individuals. |
| 348) implant interface in all groups, only low-risk individuals exhibited suppression of |
| |